
Vascular Interventional Balloon Product Developer


DKutting®LL continues to use DK Medtech's unique patented triangular nitinol winding technology, combined with the actual clinical needs of lower limb arteries, significantly increasing the length of the scoring element (up to 150mm). It has also developed a new fully coaxial balloon delivery system compatible with 0.014"/0.018" guidewires, and enriched the selection of balloon diameters with 0.5mm increments.
DK Medtech's unique directional scoring balloon boasts comprehensive performance with robust radial expansion and flexible axial bending. Its clinical performance has been widely recognized in both the coronary and hemodialysis access fields. The latest development, DKutting®LL Scoring Balloon is specifically designed for lower limb arterial intervention, demonstrating significant clinical advantages in directional dilation mechanisms, and setting a new standard for peripheral vascular pre-dilation.
DK Medtech Special Release【Professor Zhou Weimin's Team: DKutting by DK Medtech】®A Case of LL Scoring Balloon Treatment for Femoral Artery ISR, demonstrating the meticulous operation of each case and the clinical application of advanced equipment and instruments. From the formulation of treatment strategies for different cases, standardized intraoperative procedures and technical applications, complication prevention, to perioperative management, etc., the aim is to promote the standardization of diagnosis and treatment for vascular stenosis and occlusive diseases, strengthen technical exchanges and experience sharing among doctors, with the hope of providing new ideas and methods for future diagnosis and treatment, benefiting more clinical patients.
DKutting®LL Scoring Balloon
Treatment of Femoral Artery ISR: A Case Report
The Second Affiliated Hospital of Nanchang University
Zhou Weimin, Zeng Qingfu, Zhu Xianhua, Xu Yingqi, Fang Huaqiang, Liu Jingwen
Patient Information
Basic Information:Male, 84 years old.
Chief Complaint:Left lower limb pain for more than 1 month.
History of Present Illness:The patient reported that more than a year ago, without obvious cause, swelling and pain appeared in the left lower limb, which was related to walking, accompanied by numbness in both lower limbs. The left lower limb could not dorsiflex. Then, the patient went to the local hospital for treatment. After conservative treatment with drugs such as promoting blood circulation and removing blood stasis, the condition did not improve. In March this year, the patient was hospitalized in our hospital, and relevant examinations such as CT were completed. The diagnosis was "lower extremity arteriosclerosis obliterans." The patient underwent "left lower extremity arteriography, femoral artery balloon dilation stent angioplasty." In the past month, the affected limb has experienced pain again. Today, the patient came to our hospital for treatment and was admitted to our department with "lower extremity arteriosclerosis obliterans" in the outpatient clinic. Since the onset of the disease, the patient's spirit, appetite, and sleep have been fine, and there has been no significant change in weight.
Past Medical History:Hypertension and diabetes for many years, self-reported blood pressure and blood sugar under control.
Physical Examination:The color of the left lower limb showed no obvious pallor, with scattered slight skin pigmentation visible. The distal phalanx of the fifth toe of the left foot was blackened; no skin ulceration, erythema, or swelling were observed elsewhere. Femoral artery pulses were palpable bilaterally, essentially symmetrical in strength and normal. Obvious pulsations were detected in the right popliteal artery, dorsalis pedis artery, and posterior tibial artery; no pulsations were detected in the left popliteal artery or dorsalis pedis artery. No significant abnormalities in skin sensation were noted in both lower limbs and feet, and limb motor function was essentially normal.
Admission Diagnosis:
Arteriosclerosis Obliterans of the Left Lower Limb with Gangrene (Postoperative Status);
Hypertension Grade 2;
Type 2 Diabetes.
Previous interventional treatment
Time | Main Treatment Process |
2024.3.7 | Left Femoral Artery STENT, Left Anterior Tibial Artery PTA |
Preoperative Analysis
Preoperative Analysis:Lower Extremity CTA: Changes Post Left Superficial Femoral Artery Stenting, Long-Segment Thrombosis Within the Stent, Occlusion of the Lumen.
Surgical Objective:
Main Objectives:Open the original stent in the left femoral artery;
Secondary Objectives:Below-the-Knee Arterial Balloon Dilation.
Surgical Strategy/Plan:
UseDK Medtech 4.0*150mm DKutting®LL Scoring BalloonDilation;
Drug-Coated Balloon (DCB);
Drug-Eluting Stent (DES);
Stent Graft;
Debulking Device Combined with DCB;
Laser Ablation Combined with DCB;
Coronary Artery Bypass Grafting (CABG).
Surgical Procedure


Preoperative CTA of the First Surgery


Intraoperative DSA during the first surgery


First Surgery Postoperative DSA


Preoperative CTA This Time



Intraoperative DSA Assessment






DK Medtech 4.0*150mm DKutting® LL Scoring BalloonHandle the entire section

Contrast Imaging

5mm*300mm Drug-Coated Dilatation

Localized stenosis at the distal end of the stent

6mm*40mm Balloon Dilation




Postoperative Angiography
Follow-up
Discharge Status:
The patient's general condition is acceptable, complaining of discomfort in the lower limbs after walking.Pain relief and significant improvement in the sensation of cold limbs.No headache, nausea, abdominal pain or other discomfort. Physical examination: no edema in both lower limbs, warm skin temperature, no numbness, palpable pulsation of bilateral femoral arteries, normal movement of both lower limbs, no obvious hematoma, pseudoaneurysm or other abnormalities at the puncture site.
Long-term oral entericAspirin Tablets(1 tablet [100mg] once daily), in combination with oral administrationRivaroxaban(2.5mg, twice daily), be aware that the side effects of the medication may cause gastric ulcers or gastrointestinal bleeding, consult a gastroenterology department if necessary, and take oral acid-suppressing medication at the same time;
Long-term oral administration of Simvastatin (one tablet per day, once daily); control triglycerides to less than 1.7 mmol/L, and regularly review blood lipids;
Oral administration of Sarpogrelate Hydrochloride for at least one month (one tablet per dose, three times daily);
If you feel unwell, stop taking the medicine promptly. The specific course of medication will depend on the changes in your condition.
Case Summary
Case Characteristics:Long-segment stenosis and occlusion within the superficial femoral artery stent.
Preoperative Assessment Key Points:Stent thrombosis or intimal regeneration.
Surgical Strategy/Technical Key Points:
The guidewire passed through the occluded stent to reach the true lumen of the distal vessel.
How to achieve sufficient lumen diameter.
Features/Usage Tips of the Device:Every 120° directionally distributed scoring element ensures uniform and controllable expansion. The cross-section of the scoring element is triangular, providing precise high-pressure focus on the vessel wall. The scoring element utilizes patented nickel-titanium coil spring technology, which...DKutting®LL Scoring BalloonWith both bending compliance and vascular conformability similar to those of a standard balloon.DKutting®LL Scoring BalloonIn treating ISR lesions, it has the advantage of achieving more lumen gain compared to regular balloons and is safer than other specialty balloons.
Summary:In the treatment of lower limb arterial disease, the vessel preparation phase plays a crucial role. Although plain old balloon angioplasty (POBA) has been a commonly used treatment method, with the innovation in balloon technology,DK Medtech Scored BalloonStand Out in This Field with Advanced Design. Through its unique scoring design, it can expand the plaque inside blood vessels in an orderly manner, effectively avoiding the potential damage that may be caused by the uncontrolled expansion force of traditional balloons. This orderly expansion helps reduce elastic recoil of plaque or hyperplastic intimal tissue and lowers the risk and severity of flow-limiting dissections.

Expert Introduction

Professor Zhou Weimin
Surgeon of This Case
Director of the Vascular Surgery Department, Second Affiliated Hospital of Nanchang University,Vice President of Nanchang University Affiliated Cardiovascular and Cerebrovascular Disease Hospital,Professor, Chief Physician, Doctor of Medicine, Doctoral Supervisor, Postdoctoral Supervisor;National Committee Member of the Vascular Surgery Group, Surgery Branch, Chinese Medical Association;Standing Committee Member of the Vascular Surgery Physician Branch of the Chinese Medical Doctor Association and Deputy Group Leader of the Complications Study Group;Chairman of the Vascular Surgery Branch of the Jiangxi Medical Association;President of the Vascular Surgery Branch of the Jiangxi Province Medical Association;Chairman of the Vascular Medicine Branch of the Jiangxi Province Research Hospital Association;Director of the Chinese Research Hospital Association;Vice Chairman of the Peripheral Vascular Disease Branch of the Chinese Society for Microcirculation;Healthcare Expert for Cadres of the Jiangxi Provincial Committee of the Communist Party of China.
Professor Xu Yingqi
The Surgeon of This Case
The Second Affiliated Hospital of Nanchang University, Attending Physician;Served as a Youth Committee Member of the Vascular Medicine Branch of the Jiangxi Province Research-Oriented Hospital Association;Member of the Vascular Surgery Physician Branch of the Jiangxi Province Medical Association;Young Committee Member of the International Vascular Society.
Focuses on the research of vascular surgery-related diseases, has won one Jiangxi Provincial Medical Science and Technology Award, completed two research projects, and published six SCI papers. Skilled in the diagnosis and treatment of specialized vascular surgery diseases, including aortic diseases, lower limb arterial diseases, lower limb venous diseases, and arteriovenous malformations, etc. Also proficient in the establishment and maintenance of vascular access for uremic patients.

Department Introduction


The Vascular Surgery Department of the Second Affiliated Hospital of Nanchang University was established in 1994. It is the earliest independently structured vascular surgery specialty in Jiangxi Province, recognized as a national key clinical specialty construction unit, a leading medical discipline in Jiangxi Province, one of the first national training bases for peripheral vascular interventional treatment by the National Health Commission (one of 50 nationwide and the only one in Jiangxi Province), a sub-center of the National Radiology and Treatment Clinical Medical Research Center (the only one in the field of vascular surgery in Jiangxi), a peripheral vascular interventional construction center for capacity building and continuing education under the National Health Commission, the Jiangxi Cardiovascular Disease Medical Center, and the Jiangxi Training Center of the Chinese Vascular Surgery Training Project.
Copyright Statement: This platform aims to help healthcare professionals better understand the latest developments in relevant disease areas. The information published on this platform does not imply agreement with its descriptions or viewpoints; it is only intended to provide more information. If there are any copyright issues, we kindly request the rights holders to contact us, and we will address them as soon as possible. This information is solely for healthcare professionals to stay informed, and such information cannot replace professional medical guidance in any way, nor should it be considered as medical advice. If such information is used for purposes other than staying informed, this platform and its authors shall not bear any related responsibilities.Contact Email for Cooperation:vascular@edoctor.work。
